Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO)

Although many studies have shown that administration of stem cells after focal cerebral ischemia improves brain damage, very little data are available concerning the damage induced by global cerebral ischemia. The latter causes neuronal death in selectively vulnerable areas, including the hippocampa...

Full description

Saved in:
Bibliographic Details
Main Authors: Luisa Perasso, Carla Emilia Cogo, Debora Giunti, Carlo Gandolfo, Piero Ruggeri, Antonio Uccelli, Maurizio Balestrino
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2010/534925
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558506213900288
author Luisa Perasso
Carla Emilia Cogo
Debora Giunti
Carlo Gandolfo
Piero Ruggeri
Antonio Uccelli
Maurizio Balestrino
author_facet Luisa Perasso
Carla Emilia Cogo
Debora Giunti
Carlo Gandolfo
Piero Ruggeri
Antonio Uccelli
Maurizio Balestrino
author_sort Luisa Perasso
collection DOAJ
description Although many studies have shown that administration of stem cells after focal cerebral ischemia improves brain damage, very little data are available concerning the damage induced by global cerebral ischemia. The latter causes neuronal death in selectively vulnerable areas, including the hippocampal CA1 region. We tested the hypothesis that intravenous infusion of bone marrowderived stromal cells (mesenchimal stem cells, MSC) reduce brain damage after transient global ischemia. In adult male Sprague-Dawley rats transient global ischemia was induced using bilateral common carotid artery occlusion for 20 min in addition to controlled hypotension. Five days after, the animals were anaesthetized with urethane and the brain was fixed, sectioned and stained with hematoxylin-eosin to investigate histological damage. MSC did not fully protect against ischemic damage, as the number of viable neurons in this group was lower than in normal (sham-operated) rats. However, in MSC-treated rats the number of viable CA1 pyramidal neurons was significally higher than in rats that had been subjected to ischemia but not treated with MSC. We conclude that intravenous administration of MSC after transient global ischemia reduces hippocampal damage.
format Article
id doaj-art-252b510184d34ab7b95e4ada14019c0f
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-252b510184d34ab7b95e4ada14019c0f2025-02-03T01:32:12ZengWileyNeural Plasticity2090-59041687-54432010-01-01201010.1155/2010/534925534925Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO)Luisa Perasso0Carla Emilia Cogo1Debora Giunti2Carlo Gandolfo3Piero Ruggeri4Antonio Uccelli5Maurizio Balestrino6Department of Neuroscience, Ophthalmology and Genetics, University of Genova, Via De Toni 5, 16132 Genova, ItalyDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV 3, 16132 Genova, ItalyDepartment of Neuroscience, Ophthalmology and Genetics, University of Genova, Via De Toni 5, 16132 Genova, ItalyDepartment of Neuroscience, Ophthalmology and Genetics, University of Genova, Via De Toni 5, 16132 Genova, ItalyDepartment of Experimental Medicine, University of Genova, Viale Benedetto XV 3, 16132 Genova, ItalyDepartment of Neuroscience, Ophthalmology and Genetics, University of Genova, Via De Toni 5, 16132 Genova, ItalyDepartment of Neuroscience, Ophthalmology and Genetics, University of Genova, Via De Toni 5, 16132 Genova, ItalyAlthough many studies have shown that administration of stem cells after focal cerebral ischemia improves brain damage, very little data are available concerning the damage induced by global cerebral ischemia. The latter causes neuronal death in selectively vulnerable areas, including the hippocampal CA1 region. We tested the hypothesis that intravenous infusion of bone marrowderived stromal cells (mesenchimal stem cells, MSC) reduce brain damage after transient global ischemia. In adult male Sprague-Dawley rats transient global ischemia was induced using bilateral common carotid artery occlusion for 20 min in addition to controlled hypotension. Five days after, the animals were anaesthetized with urethane and the brain was fixed, sectioned and stained with hematoxylin-eosin to investigate histological damage. MSC did not fully protect against ischemic damage, as the number of viable neurons in this group was lower than in normal (sham-operated) rats. However, in MSC-treated rats the number of viable CA1 pyramidal neurons was significally higher than in rats that had been subjected to ischemia but not treated with MSC. We conclude that intravenous administration of MSC after transient global ischemia reduces hippocampal damage.http://dx.doi.org/10.1155/2010/534925
spellingShingle Luisa Perasso
Carla Emilia Cogo
Debora Giunti
Carlo Gandolfo
Piero Ruggeri
Antonio Uccelli
Maurizio Balestrino
Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO)
Neural Plasticity
title Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO)
title_full Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO)
title_fullStr Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO)
title_full_unstemmed Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO)
title_short Systemic Administration of Mesenchymal Stem Cells Increases Neuron Survival after Global Cerebral Ischemia In Vivo (2VO)
title_sort systemic administration of mesenchymal stem cells increases neuron survival after global cerebral ischemia in vivo 2vo
url http://dx.doi.org/10.1155/2010/534925
work_keys_str_mv AT luisaperasso systemicadministrationofmesenchymalstemcellsincreasesneuronsurvivalafterglobalcerebralischemiainvivo2vo
AT carlaemiliacogo systemicadministrationofmesenchymalstemcellsincreasesneuronsurvivalafterglobalcerebralischemiainvivo2vo
AT deboragiunti systemicadministrationofmesenchymalstemcellsincreasesneuronsurvivalafterglobalcerebralischemiainvivo2vo
AT carlogandolfo systemicadministrationofmesenchymalstemcellsincreasesneuronsurvivalafterglobalcerebralischemiainvivo2vo
AT pieroruggeri systemicadministrationofmesenchymalstemcellsincreasesneuronsurvivalafterglobalcerebralischemiainvivo2vo
AT antoniouccelli systemicadministrationofmesenchymalstemcellsincreasesneuronsurvivalafterglobalcerebralischemiainvivo2vo
AT mauriziobalestrino systemicadministrationofmesenchymalstemcellsincreasesneuronsurvivalafterglobalcerebralischemiainvivo2vo